Fund Details
Beijing Pharmaceutical and Health Industry Investment Fund
Overview
Investment fund focused on the medical and health industry.
Founded
2023
Deals · 12mo
4
Links
Stage focus
Series A
Series C
Geographic focus
China
United States
Sector focus
—
Investment portfolio
7rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Oricell Therapeutics | Apr 2026Led | $110 MOther Equity | |
BCIFlex | Feb 2026Participated | $43 MSeries A | |
Oricell Therapeutics | Jan 2026Led | $70 MSeries C | |
DP Technology | Dec 2025Participated | $114 MSeries C | |
BCIFlex | Aug 2025Participated | $42 MSeries A | |
METiS Technologies | Aug 2025Led | $56 MSeries D | |
Qi Biodesign | Dec 2024Led | $75 MSeries A | |
Oricell Therapeutics | Apr 2026Led | $110 MOther Equity | |
BCIFlex | Feb 2026Participated | $43 MSeries A | |
Oricell Therapeutics | Jan 2026Led | $70 MSeries C | |
DP Technology | Dec 2025Participated | $114 MSeries C | |
BCIFlex | Aug 2025Participated | $42 MSeries A | |
METiS Technologies | Aug 2025Led | $56 MSeries D | |
Qi Biodesign | Dec 2024Led | $75 MSeries A |
7 Items
7
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 2 |
| Series C+ | 2 | 1 |
| Other Equity | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Dec '24 | 1 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 2 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| AI & Machine Learning | 2 |
| Professional Services | 2 |
| Space & Frontier Tech | 2 |
| Consumer & Lifestyle | 2 |
| Food & Agriculture | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 2 |
| $50M-$100M | 3 |
| $100M-$250M | 2 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| China | 6 |
| United States | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Baidu Ventures | 2 |
| DragonBall Capital | 2 |
| Elikon Venture | 2 |
| IDG Capital | 2 |
| Legend Capital | 2 |
| Lenovo Capital | 2 |
| NGS Super | 2 |
| Qiming Venture Partners | 2 |
| Talon Capital | 2 |
| Apricot Capital | 1 |
| Beijing Artificial Intelligence Industry Investment Fund | 1 |
| China Life Capital | 1 |
| CSSD Capital | 1 |
| Daxing Industrial Investment Fund | 1 |
| Gaorong Capital | 1 |
| Hongshan Capital Group (Sequoia Capital China) | 1 |
| Jia Yin Capital | 1 |
| Mingzhe Capital | 1 |
| Shang Capital | 1 |
| Shunwei Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 57% |
| Participating | 3 | 43% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 25% |
| Co-led | 3 | 75% |
Team
No team members found for this fund.